Skip to main content
Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy
ABBV logo

NYSE · HEALTHCARE · Holders

AbbVie Inc (ABBV) Institutional Ownership & Insider Trading History

Top ABBV institutional shareholders, filing changes, and Form 4 insider activity with filters for buys, sales, option exercises, gifts, and tax withholding.

Section freshness

Price Jun 23, 4:02 PM EDT · Statements Mar 30, 8:00 PM EDT

Source timingDetails

Data freshness

Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.

Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.

PriceLive
Last traded
Source: Market data provider
Fundamentalsevery 1 hr
Provider checked
Source: Market data provider
Analystevery 1 hr
Provider checked
Source: Market data provider
Newsevery 15 min
Latest item
Source: Market data provider

Ownership read

ABBV insider sentiment: Net selling.

VANGUARD GROUP INC is the largest institutional holder. 8 sales and 0 purchases appear in the recent Form 4 filings. Use the filters below to separate real buying and selling from option exercises, gifts, awards, and tax withholding.

Insider flow

ABBV

Purchases
Sales373.99K

Directional bars ignore awards, gifts, conversions, and tax withholding rows.

Top holder

180.78M

VANGUARD GROUP INC

Insider stance

Net selling

$76.55M sold / — bought

Latest filing

May 8, 2026

Most recent holder or insider filing date

Filings shown

212

120 holder / 92 insider

Holder rows
120
Market data source
Latest filing
May 8, 2026
Most recent holder or insider filing date
Increased / initiated
66
51 decreased
Insider rows
92
Market data source

Top 120 institutional holders

AbbVie Inc (ABBV) institutional ownership

Ranked by reported share count, with position changes and latest filing dates where ownership data supplies them.

VANGUARD GROUP INC

Rank #1

10.2%

Shares
180.78M
Change
+3.03M
Change %
+1.71%
Filing
Dec 31, 2025

Increased

BLACKROCK

Rank #2

8.48%

Shares
150.70M
Change
-476.42K
Change %
-32.00%
Filing
Mar 31, 2026

Decreased

VANGUARD CAPITAL MANAGEMENT LLC

Rank #3

6.47%

Shares
114.88M
Change
+114.88M
Change %
Filing
Mar 31, 2026

Initiated

STATE STREET CORP

Rank #4

4.57%

Shares
81.22M
Change
+276.58K
Change %
+34.00%
Filing
Mar 31, 2026

Increased

JPMORGAN CHASE & CO

Rank #5

3.19%

Shares
56.74M
Change
+4.35M
Change %
+8.30%
Filing
Mar 31, 2026

Increased

VANGUARD PORTFOLIO MANAGEMENT LLC

Rank #6

2.79%

Shares
49.52M
Change
+49.52M
Change %
Filing
Mar 31, 2026

Initiated

GEODE CAPITAL MANAGEMENT

Rank #7

2.63%

Shares
46.74M
Change
+2.11M
Change %
+4.72%
Filing
Mar 31, 2026

Increased

MORGAN STANLEY

Rank #8

2.14%

Shares
38.02M
Change
-2.03M
Change %
-5.06%
Filing
Mar 31, 2026

Decreased

CAPITAL RESEARCH GLOBAL INVESTORS

Rank #9

1.76%

Shares
31.25M
Change
+5.85M
Change %
+23.01%
Filing
Mar 31, 2026

Increased

NORGES BANK

Rank #10

1.44%

Shares
25.67M
Change
+2.57M
Change %
+11.11%
Filing
Dec 31, 2025

Increased

BANK OF AMERICA CORP

Rank #11

1.35%

Shares
23.94M
Change
-1.89M
Change %
-7.31%
Filing
Mar 31, 2026

Decreased

FMR LLC

Rank #12

1.23%

Shares
21.76M
Change
-846.69K
Change %
-3.75%
Filing
Mar 31, 2026

Decreased

NORTHERN TRUST CORP

Rank #13

1.19%

Shares
21.21M
Change
-522.54K
Change %
-2.40%
Filing
Mar 31, 2026

Decreased

CAPITAL WORLD INVESTORS

Rank #14

0.89%

Shares
15.84M
Change
+2.77M
Change %
+21.19%
Filing
Mar 31, 2026

Increased

GOLDMAN SACHS GROUP INC

Rank #15

0.85%

Shares
15.15M
Change
+2.15M
Change %
+16.54%
Filing
Mar 31, 2026

Increased

FRANKLIN RESOURCES INC

Rank #16

0.82%

Shares
14.55M
Change
-329.44K
Change %
-2.21%
Filing
Mar 31, 2026

Decreased

CAPITAL INTERNATIONAL INVESTORS

Rank #17

0.81%

Shares
14.42M
Change
+2.73M
Change %
+23.32%
Filing
Mar 31, 2026

Increased

UBS AM

Rank #18

0.80%

Shares
14.16M
Change
+1.24M
Change %
+9.57%
Filing
Mar 31, 2026

Increased

UBS GROUP AG

Rank #19

0.79%

Shares
14.05M
Change
+3.52M
Change %
+33.48%
Filing
Mar 31, 2026

Increased

BANK OF NEW YORK MELLON CORP

Rank #20

0.75%

Shares
13.28M
Change
-221.19K
Change %
-1.64%
Filing
Mar 31, 2026

Decreased

Showing 20 of 120 matching institutional rows.Load more institutions

Recent insider transactions

AbbVie Inc (ABBV) Form 4 filings

Action codes are translated so open-market buys and sales are separate from awards, gifts, conversions, and tax withholding.

Quaggin Susan E

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
3.64K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

Davis Jennifer L.

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
3.64K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

MEYER MELODY B

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
17.62K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

BURNSIDE WILLIAM H.L.

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
28.08K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

Hart Brett J

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
20.59K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

Roberts Rebecca B

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
14.85K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

FREYMAN THOMAS C

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
127.87K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

WADDELL FREDERICK H

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
30.08K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

FALK THOMAS J

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
2.32K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

RAPP EDWARD J

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
45.96K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

AUSTIN ROXANNE S

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
39.58K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed May 8, 2026

Quaggin Susan E

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
784
% company
<0.01%
Price
$217.49
Value
$170,512

Filed Mar 31, 2026

Alpern Robert J

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
10.37K
% company
<0.01%
Price
$217.49
Value
$2,255,154

Filed Mar 31, 2026

RAPP EDWARD J

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
28.86K
% company
<0.01%
Price
$217.49
Value
$6,277,849

Filed Mar 31, 2026

Purdue David Ryan

SaleOpen-market or direct sale reported on Form 4.
Shares
2.65K
% company
<0.01%
Price
$233.56
Value
$619,868

Filed Mar 4, 2026

Siatis Perry C

SaleOpen-market or direct sale reported on Form 4.
Shares
4.62K
% company
<0.01%
Price
$235.26
Value
$1,086,666

Filed Mar 2, 2026

Siatis Perry C

SaleOpen-market or direct sale reported on Form 4.
Shares
7.22K
% company
<0.01%
Price
$234.66
Value
$1,694,011

Filed Mar 2, 2026

Siatis Perry C

SaleOpen-market or direct sale reported on Form 4.
Shares
17.51K
% company
<0.01%
Price
$233.51
Value
$4,088,760

Filed Mar 2, 2026

Purdue David Ryan

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
8.47K
% company
<0.01%
Price
$232.08
Value
$1,965,253

Filed Feb 27, 2026

Crum Demetris D

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
7.91K
% company
<0.01%
Price
$232.08
Value
$1,836,681

Filed Feb 27, 2026

Purdue David Ryan

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
7.88K
% company
<0.01%
Price
$232.08
Value
$1,829,719

Filed Feb 27, 2026

Thakkar Roopal

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
52.38K
% company
<0.01%
Price
$232.08
Value
$12,155,422

Filed Feb 27, 2026

Siatis Perry C

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
23.29K
% company
<0.01%
Price
$232.08
Value
$5,404,447

Filed Feb 27, 2026

Reents Scott T

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
38.78K
% company
<0.01%
Price
$232.08
Value
$8,999,366

Filed Feb 27, 2026

Donoghoe Nicholas

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
74.43K
% company
<0.01%
Price
$232.08
Value
$17,273,714

Filed Feb 27, 2026

Stewart Jeffrey Ryan

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
83.17K
% company
<0.01%
Price
$232.08
Value
$19,302,326

Filed Feb 27, 2026

Michael Robert A.

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
178.74K
% company
0.01%
Price
$232.08
Value
$41,481,283

Filed Feb 27, 2026

SALEKI-GERHARDT AZITA

Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale.
Shares
197.79K
% company
0.01%
Price
$232.08
Value
$45,904,032

Filed Feb 27, 2026

Siatis Perry C

Option exerciseDerivative exercise or conversion before any separate sale row.
Shares
14.58K
% company
<0.01%
Price
$192.86
Value
$2,812,477

Filed Feb 25, 2026

Siatis Perry C

Option exerciseDerivative exercise or conversion before any separate sale row.
Shares
7.77K
% company
<0.01%
Price
$175.28
Value
$1,362,627

Filed Feb 25, 2026

Siatis Perry C

Option exerciseDerivative exercise or conversion before any separate sale row.
Shares
% company
Price
$149.62
Value
No cash value

Filed Feb 25, 2026

Siatis Perry C

SaleOpen-market or direct sale reported on Form 4.
Shares
38.14K
% company
<0.01%
Price
$230.00
Value
$8,771,510

Filed Feb 25, 2026

Siatis Perry C

Option exerciseDerivative exercise or conversion before any separate sale row.
Shares
60.52K
% company
<0.01%
Price
$192.86
Value
$11,671,501

Filed Feb 25, 2026

Siatis Perry C

Option exerciseDerivative exercise or conversion before any separate sale row.
Shares
53.23K
% company
<0.01%
Price
$175.28
Value
$9,329,453

Filed Feb 25, 2026

Siatis Perry C

Option exerciseDerivative exercise or conversion before any separate sale row.
Shares
45.45K
% company
<0.01%
Price
$149.62
Value
$6,800,379

Filed Feb 25, 2026

Crum Demetris D

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
13.41K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Crum Demetris D

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
9.51K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Crum Demetris D

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
8.26K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Purdue David Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
4.88K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Purdue David Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
10.58K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Purdue David Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
9.19K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Purdue David Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
7.90K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Purdue David Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
7.01K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Thakkar Roopal

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
21.94K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Thakkar Roopal

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
60.41K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Thakkar Roopal

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
53.77K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Thakkar Roopal

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
50.43K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Thakkar Roopal

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
48.29K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Siatis Perry C

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
19.50K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Siatis Perry C

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
38.14K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Siatis Perry C

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
32.33K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Siatis Perry C

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
26.70K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Siatis Perry C

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
20.91K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Reents Scott T

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
21.94K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Reents Scott T

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
60.41K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Reents Scott T

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
53.16K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Reents Scott T

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
45.55K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Reents Scott T

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
36.64K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Donoghoe Nicholas

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
20.31K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Donoghoe Nicholas

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
87.30K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Donoghoe Nicholas

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
81.08K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Donoghoe Nicholas

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
75.91K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Donoghoe Nicholas

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
71.28K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Stewart Jeffrey Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
26.81K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Stewart Jeffrey Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
106.98K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Stewart Jeffrey Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
98.00K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Stewart Jeffrey Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
88.56K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Stewart Jeffrey Ryan

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
79.30K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Michael Robert A.

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
81.25K
% company
<0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Michael Robert A.

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
215.26K
% company
0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Michael Robert A.

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
193.14K
% company
0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Michael Robert A.

Award / grantAward, grant, or acquisition under an equity compensation plan.
Shares
178.68K
% company
0.01%
Price
No cash value
Value
No cash value

Filed Feb 18, 2026

Showing 72 of 92 matching Form 4 rows. Percent of company uses current shares outstanding when available.Load more insiders

Frequently asked

Common questions.

Who are the largest ABBV shareholders?

VANGUARD GROUP INC is the largest institutional holder of ABBV, with 180.78 million shares, or about 10.18% of shares outstanding. Additional institutions are ranked by reported share count.

What is institutional ownership of ABBV?

AbbVie Inc (ABBV) has 120 institutional holders on file — 66 that increased or initiated positions and 51 that reduced them, as of the latest filing on Mar 31, 2026.

Where can I see AbbVie Inc insider transactions?

AbbVie Inc (ABBV) has 92 Form 4 insider transactions on file, most recently on May 8, 2026, separated into purchases, sales, option exercises, awards, gifts, and tax withholding so administrative transactions are distinguished from open-market trades.

Are ABBV insiders buying or selling?

Recent ABBV insider activity reads Net selling: 8 sales and 0 purchases. Awards, gifts, conversions, and tax withholding are listed separately because they do not carry the same signal as open-market trades.

Who is the most active ABBV insider?

SALEKI-GERHARDT AZITA is the most active ABBV insider by absolute share movement, with 1.43 million shares moving across the filing history. Review the action labels before treating that activity as buying or selling.